M. Lindsay Grayson
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 24
-
- Antibiotic Use and Resistance 7
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 33
- Infection Control in Healthcare 14
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
- Microbiology top 1%
-
- Streptococcal Infections and Treatments 10
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Mycobacterium research and diagnosis 5
- Co-authors
- Paul D. R. JohnsonBenjamin P. HowdenTimothy P. StinearElizabeth A. GrabschJohn K. DaviesSusan A. BallardPatrick G. P. CharlesPeter Ward
- Journals
- Nature Communications (1 paper)PLoS ONE (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- AustraliaUnited StatesSwitzerland
In The Last Decade
M. Lindsay Grayson
71 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Clinical Biochemistry 1.6k
- Applied Microbiology and Biotechnology 405
- Infectious Diseases 3.0k
- Molecular Medicine 490
- Microbiology 383
Countries citing papers authored by M. Lindsay Grayson
This map shows the geographic impact of M. Lindsay Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lindsay Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lindsay Grayson more than expected).
Fields of papers citing papers by M. Lindsay Grayson
This network shows the impact of papers produced by M. Lindsay Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lindsay Grayson. The network helps show where M. Lindsay Grayson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Lindsay Grayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 34 | |
| 2 | 2022 | 26 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 15 | |
| 5 | 2014 | 16 | |
| 6 | 2013 | 13 | |
| 7 | 2012 | 51 | |
| 8 | 2011 | 32 | |
| 9 | 2011 | 5 | |
| 10 | 2011 | 6 | |
| 11 | Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implicationsbreakdown → | 2010 | 720 |
| 12 | 2010 | 73 | |
| 13 | 2008 | 49 | |
| 14 | 2007 | 31 | |
| 15 | 2006 | 50 | |
| 16 | 2004 | 316 | |
| 17 | 2004 | 396 | |
| 18 | 2002 | 63 | |
| 19 | 1999 | 58 | |
| 20 | Returning from overseas with an illness | 1998 | 1 |
About M. Lindsay Grayson
M. Lindsay Grayson is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 74 papers that have together received 4.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (33 papers), Bacterial Identification and Susceptibility Testing (24 papers), Infection Control in Healthcare (14 papers), Streptococcal Infections and Treatments (10 papers), Antibiotic Resistance in Bacteria (9 papers), Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Mycobacterium research and diagnosis (5 papers). The work is most often cited by research in Clinical Biochemistry (1.6k citations), Applied Microbiology and Biotechnology (405 citations) and Infectious Diseases (3.0k citations). M. Lindsay Grayson has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Paul D. R. Johnson, Benjamin P. Howden, Timothy P. Stinear, Elizabeth A. Grabsch, John K. Davies, Susan A. Ballard, Patrick G. P. Charles, Peter Ward, Barrie C. Mayall and John Turnidge. Their work appears in journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.